945 results on '"Socci, Nicholas D."'
Search Results
2. CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradation
3. Cancer-associated Histone H3 N-terminal arginine mutations disrupt PRC2 activity and impair differentiation
4. Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer
5. Author Correction: Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer
6. The endogenous repertoire harbors self-reactive CD4+ T cell clones that adopt a follicular helper T cell-like phenotype at steady state
7. Recurrent Mutations in Cyclin D3 Confer Clinical Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia
8. Utility of circulating tumor DNA (ctDNA) from cerebrospinal fluid (CSF) for prognosis of patients with recurrent high grade glioma.
9. Ordered and deterministic cancer genome evolution after p53 loss
10. Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets
11. Genomic and transcriptomic analysis of a library of small cell lung cancer patient-derived xenografts
12. Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation
13. FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation
14. An autoimmune stem-like CD8 T cell population drives type 1 diabetes
15. Figure S2 from Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation
16. Supplementary Tables from Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation
17. Data from Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation
18. Impact of tumor heterogeneity and microenvironment in identifying neoantigens in a patient with ovarian cancer
19. ACK1 and BRK non-receptor tyrosine kinase deficiencies are associated with familial systemic lupus and involved in efferocytosis
20. Supplementary Table S3 from PDGFRβ Signaling Cooperates with β-Catenin to Modulate c-Abl and Biologic Behavior of Desmoid-Type Fibromatosis
21. Data from PDGFRβ Signaling Cooperates with β-Catenin to Modulate c-Abl and Biologic Behavior of Desmoid-Type Fibromatosis
22. Supplementary Data 1 from PDGFRβ Signaling Cooperates with β-Catenin to Modulate c-Abl and Biologic Behavior of Desmoid-Type Fibromatosis
23. Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation
24. Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients
25. Comprehensive evaluation of differential expression analysis methods for RNA-seq data
26. PDGFRβ signaling cooperates with β-catenin to modulate c-Abl and biologic behavior of desmoid-type fibromatosis
27. Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma
28. Non-equilibrium raft-like membrane domains under continuous recycling
29. Tumour lineage shapes BRCA-mediated phenotypes
30. A study of accuracy and precision in oligonucleotide arrays: extracting more signal at large concentrations
31. Comprehensive genomic characterization of squamous cell lung cancers
32. Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
33. Supplementary Table 1 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
34. Supplementary Table 2 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
35. Supplementary Figure 6 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
36. Supplementary Figure 3 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
37. Supplementary Figure 4 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
38. Supplementary Figure 5 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
39. Supplementary Figure 1 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
40. Supplementary Figure 2 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
41. Tissue-specific features of the T cell repertoire after allogeneic hematopoietic cell transplantation in human and mouse
42. Supplementary Table S2 from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach
43. Data from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach
44. Supplementary Figure S1 from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach
45. Functional copy-number alterations in cancer.
46. Role for Stearoyl-CoA Desaturase-1 in Leptin-Mediated Weight Loss
47. Landscape Approaches for Determining the Ensemble of Folding Transition States: Success and Failure Hinge on the Degree of Frustration
48. Kinetic and thermodynamic analysis of proteinlike heteropolymers: Monte Carlo histogram technique
49. Stretching Lattice Models of Protein Folding
50. MicroRNA profiling of the murine hematopoietic system
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.